[Prevention and treatment of edema due to arterial revascularization].
Mean daily doses of 4-800,000 units iant. Cal. Trasylol administered i.v. for about 7 days prevented oedema and improved circulation after revascularisation surgery of the lower extremities involving the femoropopliteal axis in a large number of clinical cases.
D007611:Aprotinin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D001158:Arteries / Q000601:surgery*; D001775:Blood Circulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004487:Edema / Q000503:physiopathology / Q000517:prevention & control*; D005263:Femoral Artery / Q000601:surgery; D006801:Humans; D007866:Leg / Q000098:blood supply; D011150:Popliteal Artery / Q000601:surgery; D011183:Postoperative Complications / Q000188:drug therapy*; D014656:Vascular Surgical Procedures / Q000009:adverse effects*
D007611:Aprotinin
Prevenzione e trattamento dell'edema da rivascolarizzazione arteriosa